SULT1A1 and chronic kidney disease: The inactivation of Wnt/β-catenin signaling is involved in decreasing renal fibrosis; treating Sult1a1-KO mice with rhEPO further attenuated UUO-induced renal fibrosis, indicating the possibility of combination therapy in patients with CKD.